Skip to content
DAT Supply Log in
Botanicals · Gummies

Reishi Extract

INCI: Reishi Extract (Ganoderma lucidum extract)

Reishi (Ganoderma lucidum) is a medicinal mushroom extract used in dietary supplements for its adaptogenic and immune-support properties. It is one of the most familiar and commercially understood mushroom actives across EU and US markets. As a botanical on the EU on-hold list, Reishi has no authorised health claims under Reg. 432/2012; claim coverage must come from co-formulated nutrients.

  • stress-adaptogen
  • immune-support
  • sleep-calm
Build a formula with this ingredient
Reishi Extract

At a glance

Definition
Reishi (Ganoderma lucidum) is a medicinal mushroom extract used in dietary supplements for its adaptogenic and immune-support properties. It is one of the most familiar and commercially understood mushroom actives across EU and US markets. As a botanical on the EU on-hold list, Reishi has no authorised health claims under Reg. 432/2012; claim coverage must come from co-formulated nutrients.
Authorised wording (summary)
2 authorised statements — see "US structure-function statements" below.
Common positionings
  • stress and calm
  • immune support
  • sleep quality
  • adaptogenic wellness
  • daily vitality
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Reishi, also known as Ganoderma lucidum or Lingzhi, is a medicinal mushroom with a long history of use in traditional wellness systems. In modern dietary supplements, it is valued for its adaptogenic properties — helping the body respond to stress — and for its role in supporting immune function. The active compounds are primarily polysaccharides (beta-glucans) and triterpenoids, which are standardised in commercial extracts for consistent potency.

For private-label brands, Reishi offers a strong positioning opportunity in the growing functional mushroom category. It is commonly used in stress-and-calm, immune-support, and daily wellness formulations. Because no EU-authorised health claims exist for Reishi itself, brands typically pair it with nutrients like Vitamin C (for immune function) or Magnesium (for nervous system support) to carry claim-wording on pack.

Origin and history

Reishi has been used in traditional Chinese medicine for over 2,000 years, where it was known as the "mushroom of immortality" and reserved for royalty. It grows naturally on decaying wood in humid forests across Asia, though commercial cultivation now supplies the global supplement market. The mushroom's distinctive red, kidney-shaped cap and woody texture make it visually recognisable, though it is the powdered extract that enters supplement supply chains.

Industrial production of Reishi extract involves cultivating the mycelium or fruiting bodies on a substrate (often rice, oats, or sawdust), harvesting, drying, and then extracting with hot water or ethanol to concentrate the bioactive compounds. The extract is standardised to a specified percentage of polysaccharides or beta-glucans. Most commercial extracts used in gummies are water-soluble and heat-stable, making them suitable for gummy manufacturing.

Scientific overview

The primary bioactive compounds in Reishi are polysaccharides, particularly beta-glucans, and triterpenoids such as ganoderic acids. Beta-glucans are known to interact with immune cell receptors, supporting the body's natural immune response. Triterpenoids contribute to the mushroom's adaptogenic profile and are responsible for its characteristic bitter taste. The concentration of these compounds varies significantly between fruiting body extracts and mycelial biomass extracts, with fruiting body extracts generally considered more potent.

Bioavailability of Reishi polysaccharides is limited when taken orally, as they are large molecules that are not easily absorbed intact. However, they exert their effects partly through interaction with gut-associated immune tissue. Some manufacturers use dual-extraction (hot water and ethanol) to capture both water-soluble polysaccharides and alcohol-soluble triterpenoids. Standardisation to beta-glucan content (typically 10-30%) is the industry benchmark for quality.

From a manufacturing perspective, Reishi extract is heat-stable and soluble in gummy formulations, which is an advantage. The main challenge is taste: Reishi is intensely bitter, and effective taste-masking is essential for consumer acceptance. This is typically achieved through fruit concentrates, natural sweeteners, or encapsulated extract forms. The cost-per-mg is moderate compared to other functional mushrooms, making it accessible for mid-tier product positioning.

Why brands use Reishi Extract

Reishi is one of the most familiar and commercially understood mushroom actives across EU and US markets, which gives brands a ready-made consumer narrative. It positions well in stress-and-calm, immune-support, and daily wellness ranges — categories that continue to grow in the functional gummy segment. For brands targeting the adaptogenic wellness trend, Reishi is a foundational ingredient alongside Ashwagandha and Rhodiola.

From a formulation standpoint, Reishi extract integrates well into gummy manufacturing. It is heat-stable and soluble, so it does not require special processing conditions. The primary tradeoff is taste: the bitterness must be masked, which adds formulation complexity and may increase the sweetener or flavour budget. Brands should budget for taste-masking development in the sampling phase. DAT reviews taste-masking strategies per project and can recommend flavour profiles that work with Reishi's profile.

On pack copy, brands must observe strict claim discipline. Because Reishi is on the EU on-hold list, no health claims can be made for the ingredient itself. Any claim-wording must be directed to co-formulated nutrients with authorised claims under Reg. 432/2012. For example, a gummy containing Reishi and Vitamin C could carry the claim "Vitamin C contributes to the normal function of the immune system." DAT reviews claim strategy per project with regulatory counsel to ensure compliance.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Medium

Forms available

  • Polysaccharide-standardised extract (typically 10-30% beta-glucans), whole fruiting body extract, mycelial biomass extract

Dosage reference

Brand positioning range typically 500–5000 mg per serving. No reference-intake target reviewed per market established for Reishi. DAT confirms final dosage per project based on target market and claim strategy.

Taste & sensory

Very bitter. Requires significant taste-masking in gummy formats — typically achieved with fruit concentrates, natural sweeteners, or encapsulated extract forms.

Manufacturing notes

Mushroom extracts require polysaccharide-standardised raw materials for consistent potency. Probiotics in the same gummy require separate manufacturing and shelf-life considerations due to heat sensitivity.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

US structure-function statements

  • Supports the body's natural immune response.Structure-function (DSHEA)
  • Helps the body adapt to occasional stress.Structure-function (DSHEA)

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

Wording to avoid on pack copy

  • No disease claims — cannot state or imply Reishi cures, prevents, or treats any disease.
  • Structure-function claims must be accompanied by the FDA disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
  • No certification promises on pack until confirmed per project and batch documentation.
  • No guaranteed shelf-life until confirmed with stability data.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Structure-function claims are permitted under DSHEA (21 USC §343(r)(6)). No Daily Value (DV) has been established for Reishi under FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF·Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. CRC Press/Taylor & Francis·2011

  2. Bishop KS, Kao CH, Xu Y, Glucina MP, Paterson RR, Ferguson LR·Current Pharmaceutical Biotechnology·2015

  3. Baby S, Johnson AJ, Govindan B·Biotechnology Advances·2015

  4. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)·EFSA Journal·2011

  5. Stier H, Ebbeskotte V, Gruenwald J·Nutrition Journal·2014

Catalogue match

Product concepts featuring Reishi Extract

Private-label product concepts where Reishi Extract appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Reishi pairs well with other adaptogenic mushrooms (Lion's Mane, Cordyceps), with Magnesium for sleep positioning, and with Vitamin D for immune-support positioning.

Care when combining with

No known direct conflicts with common gummy ingredients. Bitter taste can conflict with palatability goals if not adequately masked.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Reishi Extract on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Reishi Extract.

Project handoff

Develop a formula featuring Reishi Extract

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.